-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Imbruvica in Frontline CLL/SLL: A Case-Based Approach

Program: Product Theaters
Session: IMBRUVICA® in Frontline CLL/SLL: A Case-based Approach
Monday, December 7, 2020, 10:30 AM-11:30 AM

Imran Khan, MD

Janssen Biotech, Inc., Horsham, PA

Disclosures: No relevant conflicts of interest to declare.

See more of: IMBRUVICA® in Frontline CLL/SLL: A Case-based Approach
See more of: Product Theaters